Stories
AAAS elects Keck School of Medicine of USC molecular biologist Yali Dou as 2025 fellow
Dou has broken new ground in the basic understanding of an enzyme that can cause leukemia and other cancers, and harnessed that knowledge at USC to develop potential therapies. Molecular biologist Yali …
Up to $47 million award supports collaborative eye transplant research co-led by USC
An ambitious endeavor to restore sight unites the Keck School of Medicine of USC with the University of Colorado Anschutz Medical Campus and several other institutions from academia and beyond. A federal …
$6 million grant drives potential treatment for common cause of vision loss toward the clinic
The California Institute for Regenerative Medicine (CIRM) has funded Keck School of Medicine of USC translational research advancing a therapy for dry age-related macular degeneration, one of the leading causes of blindness …
Chuck Murry: Stem cell science for healing the heart
Success in Chuck Murry’s vision for regenerating heart tissue to restore function after a heart attack would look like a radical shift in the medical landscape. Ironically enough, he chalks up his …
USC Stem Cell welcomes new leader, renowned physician-scientist Chuck Murry
Charles (Chuck) Murry, MD, PhD, has been appointed as the next head of USC Stem Cell. In that capacity, he will be the chair of the Department of Stem Cell Biology and …
USC scientist Paula Cannon takes the reins as president of the American Society of Gene and Cell Therapy
Paula Cannon, a Distinguished Professor at the Keck School of Medicine of USC, heads the world’s largest organization devoted to developing next-generation therapies that address the underlying causes of disease. USC geneticist …
USC medical school dean appointed to CIRM board
Acclaimed higher-ed leader, researcher and neuroradiologist Dr. Carolyn Meltzer, who leads the Keck School of Medicine of USC, takes on a governance role with California’s state stem cell agency. Carolyn C. Meltzer, …
Keck School of Medicine of USC orthopaedic surgery chair elected as 2024 AAAS fellow
Jay Lieberman, MD, has been recognized by the American Association for the Advancement of Science for groundbreaking research in gene therapy and work improving joint replacement surgery. The American Association for the …
National Academy of Inventors elects four Keck School of Medicine of USC faculty as senior members
The National Academy of Inventors (NAI), a nonprofit member organization that encourages inventors in higher education, has announced that four researchers from the Keck School of Medicine of USC are part of …
USC and CHLA awarded $8 million to expand access to cell and gene therapy clinical trials
The California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, has awarded a five-year, $8 million grant to the Keck School of Medicine of USC and Children’s Hospital Los Angeles (CHLA). …
Pituitary puzzle gets a new piece, revising evolutionary history
Insights into century-old controversy about key gland’s development arise from research led by the Keck School of Medicine of USC A new USC-led study suggests a change to the developmental — and …
Gene therapy research for HIV awarded $14.6 million NIH grant
An HIV research program led by scientists at USC and the Fred Hutchinson Cancer Research Center has received a five-year, $14.6 million grant from the National Institutes of Health. The team is advancing …